Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Infants (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of hematology 2013-11, Vol.98 (5), p.578-588
Hauptverfasser:	Tomizawa, Daisuke, Tawa, Akio, Watanabe, Tomoyuki, Saito, Akiko Moriya, Kudo, Kazuko, Taga, Takashi, Iwamoto, Shotaro, Shimada, Akira, Terui, Kiminori, Moritake, Hiroshi, Kinoshita, Akitoshi, Takahashi, Hiroyuki, Nakayama, Hideki, Kiyokawa, Nobutaka, Isoyama, Keiichi, Mizutani, Shuki, Hara, Junichi, Horibe, Keizo, Nakahata, Tatsutoshi, Adachi, Souichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Child Child, Preschool Chromosome Aberrations Female Hematologic and hematopoietic diseases Hematology Humans Induction Chemotherapy Infant Infant, Newborn Japan Leukemia, Myeloid, Acute - diagnosis Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - mortality Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Medicine Medicine & Public Health Oncology Original Original Article Registries Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!